Incidence was higher in Black, Hispanic or Latino, and Asian or Pacific Islander persons versus Whites
CDC Calls Emergency Meeting on Heart Inflammation Link to COVID-19 Vaccines
Agency has identified 226 reports so far that may meet its ‘working case definition’ of myocarditis and pericarditis
Drop in Kawasaki Disease Seen During the COVID-19 Pandemic
Incidence decreased sharply after implementation of nonpharmaceutical interventions, such as mask wearing; seasonal pattern absent
Most Severe Effects of PIMS-TS Resolved at Six Months
Findings generally favorable for patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
Presentation of Multisystem Inflammatory Syndrome Varies in Adults
60 percent of patients with MIS-A had acute COVID-19 symptoms, 20 percent were admitted for COVID-19 before being admitted for MIS-A
Two Peaks in MIS-C Followed COVID-19 Peaks in the US
Lowest proportion of severe manifestations seen in patients aged 0 to 4 years, but 44.3 percent admitted for intensive care
Researchers Differentiate MIS-C From Severe COVID-19 in Children
Severe cardiovascular or mucocutaneous involvement, more extreme inflammation are among distinguishing features of MIS-C
Inflammatory Heart Disease After COVID-19 Rare in Athletes
Five athletes (0.6 percent) had cardiac magnetic resonance imaging findings suggestive of inflammatory heart disease
Neurologic Involvement Common in Children Hospitalized With COVID-19
Twelve percent of those with neurologic involvement develop life-threatening conditions associated with COVID-19
Cutaneous Findings Described for Children With MIS-C
Cutaneous findings varied among patients; annular plaques in the proximal medial lower extremities were common
- Page 1 of 2
- 1
- 2